• Image: Cancer Genomic Clouds, National Cancer Institute photo.

    Numerate Intends to Join ATOM Consortium

    Computational drug design company Numerate has signed a letter of intent to join the consortium. 

    Read More View All
  • The Frederick National Laboratory GDC project team. From left: Himanso Sahni; Sharon Gaheen; and Mark Jensen. Photo by Frank Blanchard.

    Frederick National Laboratory Staff Advance Genomic Data Commons Capabilities

    “The GDC aims to be the operating system of cancer genomics." 

    Read More View All
  • Cancer nanomedicine illustration. Credit: Jenolyn F. Alexander and Biana Godin, Houston Methodist Research Institute; Veronika Kozlovskaya and Eugenia Kharlampieva, University of Alabama at Birmingham.

    Nanotechnology Laboratory Unveils New Technical Services for Drug Developers

    The technology helps fine-tune nanomedicine formulations. 

    Read More View All

  • Frederick National Laboratory and Georgetown University Launch Collaboration

    The partnership aims to expand both institutions’ research and training missions in the biomedical sciences.

    Read More View All
  • Cell images show normal cells with two centrosomes, and cancer cells treated with CFI-400945, resulting in a multiplicy of centrosomes. Source: Masanori Kawakami in PNAS.

    First-in-Class Drug Being Tested for Breast Cancer May Also Work in Lung Cancer

    The targeted treatment uses a new approach to destroy cancer cells.

    Read More View All
Who We Are Discovery, innovation, and success in the biomedical sciences. Learn More

The Frederick National Laboratory is dedicated to improving human health through discovery and innovation in the biomedical sciences, focusing on cancer, AIDS, and emerging infectious diseases.